Ventilator pneumonia in COVID-19: antibiotics failing to reach the lungs?
NCT ID NCT05464680
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at why antibiotics often fail to treat pneumonia in COVID-19 patients on ventilators. Researchers measured how much of the antibiotic piperacillin reaches the lungs in 34 adults with severe COVID-19 pneumonia. The goal was to understand if poor lung penetration explains the high rate of repeat infections, which could lead to better dosing strategies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARDS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service Médecine Intensive Réanimation
Marseille, 13015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Stem cell infusion may help severely ill COVID-19 patients breathe
- Breathing new life: tailored ventilation for ARDS patients
- Blood test may spot lung risk in brain injury patients
- Can a smartphone app heal the hidden wounds of the ICU?
- Placenta cells tested as COVID fighter – but trial stopped early
- What happens to severe COVID-19 survivors after the ICU?